🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, prospective, randomized, controlled study that will ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-10
Trial ID
NCT07027774
Treatments Being Tested
Given the significant and growing burden of Type 2 Diabetes (T2DM) in China...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-20
Trial ID
NCT07441187
Treatments Being Tested
The purpose of this study is to obtain information on efficacy and safety o...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2017-06
Trial ID
NCT03159052
The purpose of this study is to determine the superiority of the effectiven...
Status
Unknown
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2023-04-15
Trial ID
NCT05742230
Treatments Being Tested
The purpose of this study is to evaluate the pharmacodynamics (PD), pharmac...
Status
Completed
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02346175
The goal of this clinical trial is to learn if SGLT2 inhibitor Henggliflozi...
Status
Recruiting
Location
Shanghai Jiaotong University School of Medicine, Xinhua Hospital
Start Date
2025-07-14
Trial ID
NCT06818851
Treatments Being Tested
The purpose of this study is to obtain information on PK/PD, efficacy and s...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2015-02
Trial ID
NCT02366351
SHR3824 is a novel inhibitor of renal sodium-glucose cotransporter 2, allow...
Status
Completed
Location
Shanghai Xuhui Central Hospital
Start Date
2013-12
Trial ID
NCT02361138
The purpose of this study is to evaluate the efficacy and safety of 3 diffe...
Status
Unknown
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02366377
The prevalence of metabolic dysfunction-associated steatotic liver disease ...
Status
Not Yet Recruiting
Location
Jiangsu province hospital of traditional chinese medicine
Start Date
2024-12-31
Trial ID
NCT06762223
Treatments Being Tested